Interpace Biosciences (IDXG) Financial Statements
Price: $2.005
Market Cap: $8.83M
Avg Volume: 7.93K
Market Cap: $8.83M
Avg Volume: 7.93K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Interpace Biosciences.
Income Statement
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 | December 31, 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | $40.21M | $31.84M | $41.31M | $32.40M | $24.08M | $21.90M | $15.90M | $13.09M | $9.43M | $119.94M |
Cost of Revenue | $17.17M | $13.61M | $23.37M | $21.67M | $15.89M | $10.20M | $7.36M | $6.64M | $6.91M | $101.39M |
Gross Profit | $23.04M | $18.23M | $17.95M | $10.72M | $8.19M | $11.70M | $8.54M | $6.44M | $2.52M | $18.54M |
Gross Profit Ratio | 57.30% | 57.26% | 43.44% | 33.10% | 34.02% | 53.43% | 53.71% | 49.25% | 26.74% | 15.46% |
Research and Development Expenses | $636.00K | $703.00K | $1.88M | $2.79M | $2.81M | $2.12M | $1.46M | $1.65M | $2.29M | $255.00K |
General and Administrative Expenses | $9.36M | $10.97M | $13.67M | $20.77M | $14.55M | $8.50M | $9.15M | $10.50M | $16.92M | $29.15M |
Selling and Marketing Expenses | $10.23M | $9.12M | $10.07M | $9.25M | $11.12M | $8.42M | $6.57M | $5.46M | $10.36M | $604.00K |
Selling General and Administrative Expenses | $19.60M | $20.10M | $23.74M | $30.02M | $25.66M | $16.92M | $15.72M | $15.97M | $27.28M | $29.15M |
Other Expenses | $-667.00K | $1.27M | $4.06M | $4.46M | $3.65M | $263.00K | $-2.13M | $14.00K | $-93.00K | $-68.00K |
Operating Expenses | $20.23M | $22.07M | $29.68M | $37.28M | $32.12M | $22.30M | $20.43M | $21.38M | $33.38M | $29.93M |
Cost and Expenses | $37.40M | $35.68M | $53.05M | $58.95M | $48.01M | $32.49M | $27.79M | $28.02M | $40.29M | $131.32M |
Interest Income | $- | $1.01M | $1.04M | $549.00K | $440.00K | $- | $- | $- | $- | $- |
Interest Expense | $1.01M | $1.01M | $920.00K | $549.00K | $440.00K | $331.00K | $433.00K | $2.14M | $3.71M | $602.00K |
Depreciation and Amortization | $1.03M | $2.56M | $5.37M | $5.50M | $4.52M | $3.80M | $3.69M | $4.27M | $5.03M | $2.39M |
EBITDA | $3.84M | $-3.78M | $-8.18M | $-21.63M | $-20.09M | $-7.08M | $-10.77M | $-11.15M | $-25.93M | $-9.06M |
EBITDA Ratio | 9.54% | -11.88% | -19.80% | -66.75% | -83.41% | -32.34% | -67.75% | -85.25% | -274.86% | -7.55% |
Operating Income | $2.81M | $-3.84M | $-11.74M | $-26.55M | $-23.93M | $-12.12M | $-6.29M | $-6.44M | $-40.41M | $-13.47M |
Operating Income Ratio | 6.99% | -12.06% | -28.41% | -81.96% | -99.39% | -55.35% | -39.59% | -49.23% | -428.41% | -11.23% |
Total Other Income Expenses Net | $-1.68M | $-2.00M | $-3.68M | $407.00K | $-2.73M | $-1.26M | $-804.00K | $8.51M | $-9.64M | $-2.15M |
Income Before Tax | $1.13M | $-5.84M | $-15.41M | $-26.15M | $-26.67M | $-12.19M | $-13.13M | $-8.57M | $-44.21M | $-14.14M |
Income Before Tax Ratio | 2.81% | -18.33% | -37.31% | -80.71% | -110.75% | -55.66% | -82.61% | -65.51% | -468.68% | -11.79% |
Income Tax Expense | $17.00K | $29.00K | $-667.00K | $53.00K | $-28.00K | $18.00K | $-395.00K | $-162.00K | $-13.14M | $-4.74M |
Net Income | $802.00K | $-5.87M | $-14.75M | $-26.20M | $-26.64M | $-12.19M | $-12.22M | $-8.33M | $-11.36M | $-16.07M |
Net Income Ratio | 1.99% | -18.42% | -35.69% | -80.87% | -110.63% | -55.67% | -76.84% | -63.68% | -120.40% | -13.40% |
EPS | $0.19 | $-1.38 | $-3.57 | $-6.50 | $-7.11 | $-4.33 | $-7.77 | $-45.88 | $-73.38 | $-107.87 |
EPS Diluted | $0.18 | $-1.38 | $-3.57 | $-6.50 | $-7.11 | $-4.33 | $-7.75 | $-45.88 | $-73.36 | $-107.87 |
Weighted Average Shares Outstanding | 4.32M | 4.24M | 4.13M | 4.03M | 3.75M | 2.82M | 1.57M | 181.60K | 154.75K | 149.01K |
Weighted Average Shares Outstanding Diluted | 4.36M | 4.24M | 4.13M | 4.03M | 3.75M | 2.82M | 1.58M | 181.60K | 154.80K | 149.01K |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 | December 31, 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $3.50M | $4.83M | $3.31M | $2.77M | $2.32M | $6.07M | $15.20M | $602.00K | $8.31M | $23.11M |
Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $106.00K | $107.00K |
Cash and Short Term Investments | $3.50M | $4.83M | $3.31M | $2.77M | $2.32M | $6.07M | $15.20M | $602.00K | $8.42M | $23.22M |
Net Receivables | $4.98M | $5.03M | $6.16M | $8.03M | $10.20M | $9.48M | $3.44M | $2.53M | $3.85M | $14.42M |
Inventory | $1.23M | $1.22M | $1.79M | $2.05M | $1.82M | $1.23M | $266.00K | $14.00K | $5.55M | $- |
Other Current Assets | $614.00K | $180.00K | $108.00K | $45.00K | $167.00K | $940.00K | $906.00K | $1.09M | $1.34M | $7.22M |
Total Current Assets | $10.32M | $12.15M | $12.17M | $14.12M | $16.37M | $17.72M | $19.81M | $4.24M | $19.16M | $44.87M |
Property Plant Equipment Net | $2.65M | $2.92M | $10.38M | $11.73M | $10.71M | $837.00K | $654.00K | $929.00K | $1.46M | $3.18M |
Goodwill | $- | $- | $8.43M | $8.43M | $8.43M | $- | $- | $- | $- | $15.54M |
Intangible Assets | $- | $861.00K | $7.29M | $11.35M | $33.50M | $29.85M | $33.10M | $36.36M | $43.49M | $47.30M |
Goodwill and Intangible Assets | $- | $861.00K | $15.72M | $19.78M | $41.93M | $29.85M | $33.10M | $36.36M | $43.49M | $62.85M |
Long Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $905.00K | $1.06M |
Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $-905.00K | $-1.06M |
Other Non-Current Assets | $45.00K | $45.00K | $160.00K | $42.00K | $42.00K | $31.00K | $31.00K | $251.00K | $3.60M | $5.01M |
Total Non-Current Assets | $2.70M | $3.83M | $26.26M | $31.56M | $52.68M | $30.72M | $33.79M | $37.54M | $48.55M | $71.04M |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $13.02M | $15.98M | $38.43M | $45.68M | $69.05M | $48.44M | $53.60M | $41.78M | $67.71M | $115.91M |
Account Payables | $1.54M | $1.05M | $2.69M | $4.51M | $4.81M | $1.06M | $391.00K | $2.33M | $1.56M | $4.31M |
Short Term Debt | $5.48M | $3.08M | $1.12M | $1.20M | $1.50M | $- | $- | $- | $1.16M | $19.70M |
Tax Payables | $261.00K | $262.00K | $245.00K | $334.00K | $403.00K | $285.00K | $515.00K | $526.00K | $591.00K | $- |
Deferred Revenue | $261.00K | $- | $40.00K | $54.00K | $457.00K | $- | $- | $- | $8.38M | $6.75M |
Other Current Liabilities | $10.19M | $10.15M | $11.83M | $12.46M | $10.52M | $7.43M | $7.60M | $13.91M | $12.26M | $2.82M |
Total Current Liabilities | $17.47M | $14.28M | $15.68M | $18.23M | $17.30M | $8.49M | $7.99M | $16.24M | $23.37M | $33.58M |
Long Term Debt | $4.24M | $13.01M | $12.60M | $3.54M | $5.59M | $- | $- | $7.91M | $7.23M | $27.15M |
Deferred Revenue Non-Current | $- | $- | $13.00K | $136.00K | $269.00K | $- | $- | $-3.59M | $- | $581.00K |
Deferred Tax Liabilities Non-Current | $- | $- | $46.54M | $4.34M | $4.08M | $3.84M | $3.73M | $3.59M | $- | $2.52M |
Other Non-Current Liabilities | $6.44M | $51.76M | $6.02M | $48.51M | $28.79M | $3.17M | $1.90M | $11.10M | $24.07M | $31.95M |
Total Non-Current Liabilities | $10.68M | $64.77M | $65.16M | $56.53M | $38.73M | $7.01M | $5.64M | $19.01M | $31.30M | $62.21M |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $28.16M | $79.05M | $80.84M | $74.76M | $56.02M | $15.50M | $13.63M | $35.25M | $54.67M | $95.78M |
Preferred Stock | $46.54M | $46.54M | $46.54M | $45.68M | $26.17M | $- | $100.00K | $- | $- | $- |
Common Stock | $405.00K | $405.00K | $403.00K | $402.00K | $393.00K | $287.00K | $278.00K | $22.00K | $187.00K | $165.00K |
Retained Earnings | $-248.22M | $-249.02M | $-227.06M | $-212.12M | $-168.16M | $-141.49M | $-131.80M | $-119.58M | $-111.25M | $-99.90M |
Accumulated Other Comprehensive Income Loss | $-46.54M | $-0.00B | $-0.00B | $-45.68M | $-26.17M | $-1.37M | $-1.16M | $--0.00B | $13.00K | $16.00K |
Other Total Stockholders Equity | $232.67M | $139.00M | $137.70M | $182.63M | $180.79M | $175.51M | $172.55M | $126.09M | $124.09M | $119.84M |
Total Stockholders Equity | $-15.14M | $-63.07M | $-42.42M | $-29.08M | $13.03M | $32.94M | $39.97M | $6.53M | $13.04M | $20.12M |
Total Equity | $-15.14M | $-63.07M | $-42.42M | $-29.08M | $13.03M | $32.94M | $39.97M | $6.53M | $13.04M | $20.12M |
Total Liabilities and Stockholders Equity | $13.02M | $15.98M | $38.43M | $45.68M | $69.05M | $48.44M | $53.60M | $41.78M | $67.71M | $115.91M |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $13.02M | $15.98M | $38.43M | $45.68M | $69.05M | $48.44M | $53.60M | $41.78M | $67.71M | $115.91M |
Total Investments | $- | $- | $- | $- | $- | $- | $- | $- | $106.00K | $107.00K |
Total Debt | $11.19M | $16.09M | $13.72M | $4.74M | $7.10M | $- | $- | $7.91M | $8.40M | $27.15M |
Net Debt | $7.69M | $11.26M | $10.40M | $1.97M | $4.78M | $-6.07M | $-15.20M | $7.31M | $87.00K | $4.04M |
Cash Flow Statement
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 | December 31, 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | $1.11M | $-21.96M | $-14.94M | $-26.45M | $-26.73M | $-12.19M | $-12.22M | $-8.33M | $-32.99M | $-16.07M |
Depreciation and Amortization | $1.03M | $2.56M | $5.37M | $5.50M | $4.19M | $3.46M | $3.69M | $4.48M | $5.03M | $2.39M |
Deferred Income Tax | $-3.22M | $-93.00K | $38.00K | $37.00K | $18.00K | $-1.90M | $2.38M | $-4.71M | $-1.17M | $-5.04M |
Stock Based Compensation | $630.00K | $1.30M | $1.37M | $2.24M | $1.53M | $2.27M | $1.28M | $131.00K | $4.02M | $2.12M |
Change in Working Capital | $-83.00K | $-3.05M | $-1.13M | $5.23M | $-2.08M | $-3.83M | $-7.34M | $100.00K | $-6.53M | $-4.06M |
Accounts Receivables | $49.00K | $-133.00K | $2.15M | $1.73M | $-961.00K | $-3.55M | $-1.23M | $4.77M | $-5.49M | $-3.42M |
Inventory | $- | $- | $- | $- | $-730.00K | $-873.00K | $-3.92M | $-4.80M | $3.14M | $-493.00K |
Accounts Payables | $489.00K | $-735.00K | $-1.82M | $-198.00K | $-835.00K | $668.00K | $-2.63M | $143.00K | $1.02M | $786.00K |
Other Working Capital | $-621.00K | $-2.18M | $-1.46M | $3.70M | $443.00K | $-82.00K | $443.00K | $-11.00K | $-5.20M | $-929.00K |
Other Non Cash Items | $4.32M | $13.54M | $575.00K | $-1.08M | $4.11M | $3.52M | $-3.05M | $-608.00K | $11.80M | $4.27M |
Net Cash Provided by Operating Activities | $3.79M | $-7.69M | $-8.72M | $-14.58M | $-18.96M | $-8.67M | $-15.26M | $-8.94M | $-19.84M | $-16.38M |
Investments in Property Plant and Equipment | $-470.00K | $-322.00K | $-354.00K | $-1.57M | $-131.00K | $-449.00K | $-29.00K | $- | $-353.00K | $-11.35M |
Acquisitions Net | $383.00K | $6.53M | $39.00K | $- | $-13.83M | $- | $- | $- | $26.75M | $-13.36M |
Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-655.00K |
Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $8.50M |
Other Investing Activities | $383.00K | $6.53M | $39.00K | $- | $13.00K | $- | $- | $- | $26.75M | $-8.50M |
Net Cash Used for Investing Activities | $-87.00K | $6.21M | $-315.00K | $-1.57M | $-13.95M | $-449.00K | $-29.00K | $- | $26.40M | $-25.36M |
Debt Repayment | $-5.00M | $-3.00M | $-7.92M | $-3.00M | $-6.02M | $- | $- | $-1.33M | $-20.00M | $-20.00M |
Common Stock Issued | $- | $108.00K | $335.00K | $434.00K | $6.48M | $- | $23.08M | $1.71M | $451.00K | $- |
Common Stock Repurchased | $-32.00K | $-108.00K | $- | $-52.00K | $-41.00K | $-9.00K | $-28.00K | $- | $-208.00K | $-228.00K |
Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $-2.50M | $9.00M | $16.57M | $19.22M | $28.74M | $-9.00K | $6.84M | $-475.00K | $-21.60M | $19.44M |
Net Cash Used Provided by Financing Activities | $-5.03M | $3.00M | $8.98M | $16.61M | $29.16M | $-9.00K | $29.89M | $1.23M | $-21.36M | $19.21M |
Effect of Forex Changes on Cash | $-500.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Net Change in Cash | $-1.83M | $1.51M | $-58.00K | $451.00K | $-3.75M | $-9.13M | $14.60M | $-7.71M | $-14.80M | $-22.53M |
Cash at End of Period | $3.50M | $4.83M | $3.31M | $2.77M | $2.32M | $6.07M | $15.20M | $602.00K | $8.31M | $23.11M |
Cash at Beginning of Period | $5.33M | $3.31M | $3.37M | $2.32M | $6.07M | $15.20M | $602.00K | $8.31M | $23.11M | $45.64M |
Operating Cash Flow | $3.79M | $-7.69M | $-8.72M | $-14.58M | $-18.96M | $-8.67M | $-15.26M | $-8.94M | $-19.84M | $-16.38M |
Capital Expenditure | $-470.00K | $-322.00K | $-354.00K | $-1.57M | $-131.00K | $-449.00K | $-29.00K | $- | $-353.00K | $-11.35M |
Free Cash Flow | $3.32M | $-8.01M | $-9.07M | $-16.15M | $-19.09M | $-9.12M | $-15.29M | $-8.94M | $-20.20M | $-27.73M |